Skip to content

Laparoscopic-robotic Hysterectomy for Uterine Transplantation in Live-donor Patient.

Feasibility Assessment of Assisted Laparoscopic-robotic Hysterectomy for Uterine Transplantation in Live-donor Patient. Description of the Donor and Recipient Surgical Technique.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04249791
Acronym
transplant
Enrollment
6
Registered
2020-01-31
Start date
2019-06-25
Completion date
2021-06-25
Last updated
2020-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Anomaly

Keywords

uterine transplant, robotic surgery, donor, recipient, uterine anomaly

Brief summary

Currently, there is no standard and indicated standard access route for uterine removal in the uterine transplant donor patient. The aim of the study is to show the feasibility of performing this procedure by replicating in our center the results found in other recent studies and to try to reduce the surgery time for both the donor and recipient patients.

Detailed description

Few cases have been performed worldwide by laparotomic and, more recently, laparoscopic and assisted robotic access pathways. This is a clinical trial with 6 participants (3 donors and 3 recipients) to investigate the feasibility of an assisted laparoscopic-robotic surgical access route for uterine removal in the donor patient in uterine transplants. In the receiving patient, conventional surgery (midline incision) will be performed for uterine transplantation and vascular anastomoses.

Interventions

PROCEDURETransplantation of the uterus from live donor.

Laparoscopic-robotic hysterectomy for uterine transplantation in live-donor patient.

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Barretos Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Desire for uterine transplantation as a donor of the uterus (with family relationship with the donor patient); * At least one pregnancy before

Exclusion criteria

* comorbidities that contraindicate a surgical procedure * Women who do not understand the study; * Women subject to the regime that determines significant vulnerability to the participant (eg prisoners, indigenous, etc.) * ABO blood test mismatch between donor and recipient patient.

Design outcomes

Primary

MeasureTime frameDescription
transplant sucess rate2 years after transplantationAssessed by records from Barretos Cancer Hospital

Secondary

MeasureTime frameDescription
Live births after uterus transplantion2 years after transplantationAssessed by records from Barretos Cancer Hospital
Pregnancy rate2 years after transplantationAssessed by records from Barretos Cancer Hospital

Countries

Brazil

Contacts

Primary ContactMARCELO DE A VIEIRA, MD
mvieiraonco@gmail.com+ 55 1733216600
Backup ContactMARCELO DE A VIEIRA, MD
mvieiraonco@gmail.com+55 1733216600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026